ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bearishKakao Games
18 Jun 2021 11:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
487 Views
Share
14 Jun 2021 20:08

KRX Plans to Launch a New Index Called 'KOSPI 200 Top 10'

According to the KRX, it plans to launch new indices which would include the top 10 stocks in KOSPI. The name of this index is expected to be...

Logo
184 Views
Share
08 Jun 2021 17:50

Pharmaron Placement - Strong Track Record

Joint Global coordinators aim to raise around US$125m via selling shares in Pharmaron in order to aid certain convertible bond investors to hedge...

Logo
243 Views
Share
29 May 2021 06:26

Asia Shorts: Tencent, AIA, JD, CICC, Canon, Renesas, Monex, HMC, LGD, HMM, KEPCO, Innolux, Wan Hai

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
240 Views
Share
14 May 2021 09:37

Samsung Biologics Contract Manufacturing Deal with Moderna for COVID-19 Vaccines: Key Takeaways

This post summarizes key takeaways on this morning's news report about Samsung Biologics cutting a manufacturing deal with Moderna for COVID-19...

Logo
365 Views
Share
x